Rules 4.7.3 and 4.10.3 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity: ABN / ARBN: Financial year ended: Star Combo Pharma Limited 38 615 728 375 30 June 2026 2 3 Our corporate governance statement for the above period above can be found...
S66 2026 ASX Appendix 4G
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Star Combo Pharma
- S66 2026 Corporate Governance Statement
- S66 2026 AGM - NOM / EM / Proxy
- S66 2026 Annual Report
- S66 Date of 2026 AGM
- Dividend/Distribution - S66
Follow Star Combo Pharma into a list and get an email when it puts out news.
Follow Star Combo Pharma